Clinical Trial Update: Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update studying the physiopathology and pharmacological modulation of markers of glucocorticoid-induced cutaneous atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Cutaneous Atrophy

Snippet

Sponsor: Pierre Fabre Dermo Cosmetique | Conditions: Cortico Atrophy | Phase 3 | Status: UNKNOWN